Search

everythinglearnresearchcommunity

for

Search:↓

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

OCT can effectively examine and reveal details about human hair and scalp conditions.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

OCT can effectively screen and diagnose various medical conditions non-invasively.

New synthetic polymers help improve skin wound healing and can be enhanced by adding natural materials and medicines.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Sex hormones affect brain cells differently in males and females.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.